Miracor granted several U.S. patents for its PICSO®system to treat severe heart attack patients. Protection includes PICSO® method and algorithms that ensures stable and repeatable PICSO® treatment designed to improve myocardial perfusion following primary PCI in STEMI patients. “Even after a successful PCI, the mortality and morbidity following a STEMI event remains unacceptable. No doubt, primary PCI alone is not enough to deter the risk of future cardiovascular issues. We are very pleased that our proprietary dual balloon method and algorithms are now patent-protected in the United States, in addition to previously granted patents in the US, Europe and Japan.” Click here to read more…